ASX:SIG 22 March 2026 - 25 June 2026

Sigma Healthcare jumps as ASX healthcare pushes higher, Boots deal discount still in play

Sigma Healthcare jumps as ASX healthcare pushes higher, Boots deal discount still in play

Sigma Healthcare Ltd opened Friday’s ASX session coming off a Thursday gain. The move was driven more by activity in health-care stocks than renewed interest in the Chemist Warehouse parent. Sigma climbed 2.56% to A$2.80 on Thursday, matching the S&P/ASX 200 Health Care index, which also gained 2.56%. The broader S&P/ASX 200 slipped 0.68%. Sigma traded 25.74 million shares, about 48% higher than the 17.37 million share average shown by Google.
June 25, 2026
Sigma Healthcare stock stays A$2.1 billion under pre-Boots level as trading volume picks up

Sigma Healthcare stock stays A$2.1 billion under pre-Boots level as trading volume picks up

Sigma Healthcare is set to start Wednesday trading with its market cap still about A$2.1 billion under where it stood on June 9, even after the company scrapped its short-lived bid for the UK’s Boots chain. Sigma shares finished Tuesday at A$2.74, down 0.7%. They traded at A$2.92 before news of the Boots talks. With 11.54 billion shares out, the drop puts the lost market value at about A$2.08 billion.
June 23, 2026
Sigma Healthcare holds firm after Boots exit, ASX traders look to Chemist Warehouse

Sigma Healthcare holds firm after Boots exit, ASX traders look to Chemist Warehouse

Sigma Healthcare opened in the ASX pre-open Wednesday holding onto most of the rally from its failed Boots deal. The Chemist Warehouse owner ended talks to buy the UK pharmacy chain, with investors now back to focusing on Sigma’s Australian growth plans. Timing is key here. Sigma shares slid last week after it said talks with Boots were at an early stage, following a Financial Times report that suggested the deal could value Boots at nearly $10 billion. Sigma pulling out has eased worries about management getting distracted by a big overseas deal while it’s still working through the Chemist Warehouse merger.
June 16, 2026
Sigma Healthcare Rises After Chemist Warehouse Parent Pulls Boots Bid

Sigma Healthcare Rises After Chemist Warehouse Parent Pulls Boots Bid

Sigma Healthcare Ltd jumped Monday after Chemist Warehouse’s parent ended its talks to buy The Boots Group, removing a drag on the shares. Sigma closed at A$2.80, up 16 cents, or 6.06%. The stock changed hands between A$2.78 and A$2.86, market data showed. Reuters said Sigma climbed as much as 8.3% intraday. Sigma outperformed the S&P/ASX 200, which added 1.25% to 8,914.00 as other Australian shares also gained. Deal headlines can shake up shares. Traders watch risks, debt loads, or if new stock will mean dilution. Dilution can leave holders with a smaller stake after a share sale. On June 10, Sigma said it was in early talks to buy Boots. By June 15, the board announced the discussions were
June 16, 2026
Sigma Healthcare Shares Face Monday Test as Boots Deal Drama Hits ASX:SIG

Sigma Healthcare Shares Face Monday Test as Boots Deal Drama Hits ASX:SIG

Sigma Healthcare Ltd. heads into Monday’s ASX session with investors focused on whether the Chemist Warehouse owner has backed away from a possible acquisition of UK pharmacy giant Boots, after reports over the weekend said shareholder pushback had cooled the company’s appetite for a company-changing deal. Sigma’s shares last traded at A$2.64 on Friday, down 1.86% for the session, even as the S&P/ASX 200 — Australia’s main benchmark index of large listed companies — closed 1.98% higher at 8,804.04. The immediate issue for the share price is not Boots itself, but what a Boots deal would have meant: a potentially large equity raising, more debt and a major integration challenge just months after Sigma’s merger with Chemist Warehouse. Sigma told
June 14, 2026
Sigma Healthcare Drops in Sydney After Boots Bid Reports Cloud Chemist Warehouse Deal

Sigma Healthcare Drops in Sydney After Boots Bid Reports Cloud Chemist Warehouse Deal

Sigma Healthcare Ltd shares slipped this week, with the stock closing at A$2.64, down 1.86% on the day and off 9.28% for the last seven sessions, as investors weighed up if the Chemist Warehouse owner is planning a much bigger play in the UK pharmacy space. The ASX-listed company’s market data is from Intelligent Investor. The recent drop came after Sigma put out a June 10 ASX statement on talk about Boots, the pharmacy chain out of the UK. Sigma said it had some early talks about the Boots sale process but said there’s no guarantee a deal will take place.
June 12, 2026
Sigma drops as Boots pursuit puts focus on funding

Sigma drops as Boots pursuit puts focus on funding

Sigma Healthcare Ltd shares dropped Wednesday after the Chemist Warehouse owner said it has started early talks about a possible Boots Group sale. What started as a slow UK expansion is now raising bigger doubts around deal size, funding and execution. Reuters said Sigma lost more than 5% to A$2.76, the lowest close since April 28. Australia’s main index closed up 0.7%. Sigma’s interest in the UK wasn’t news for investors—they knew that part. The shift now is about scale. Sigma’s brief ASX update said it looks at deals that could boost shareholder value and has started early talks on the Boots sale. But Sigma also cautioned a deal may not happen.
June 10, 2026
Sigma Healthcare Shares in Focus With Boots Sale Deal Reported

Sigma Healthcare Shares in Focus With Boots Sale Deal Reported

Sigma Healthcare Ltd could be in focus at the ASX open after the Financial Times said Boots’ owner, Sycamore Partners, is talking with Sigma and Canada’s Weston family about selling the UK pharmacy chain for around $10 billion. That would be instead of going for a London IPO, according to the report. The FT said talks are still early, and there’s no deal yet. The timing is key here. The report dropped once Australian markets were closed, so there’s no clear signal yet on how Sigma shares will move. Sigma ended Tuesday flat at A$2.92, after a session between A$2.89 and A$2.95. Regular ASX trading goes until 16:00 Sydney, with the closeout auction just after 16:10.
June 9, 2026
ASX Opens as Banks, Miners and Oil on Radar for Next Moves

ASX Opens as Banks, Miners and Oil on Radar for Next Moves

ASX eyes muted open as miners, banks slip before long weekend Australian stocks are expected to open cautiously Tuesday, with S&P/ASX 200 futures held down by Friday’s 0.7% drop to 8,625.10 and weak trading in banks and miners. The ASX cash market didn’t trade on Monday because of the King’s Birthday holiday. Regular trading is set to start around 10 a.m. Sydney time. ASX traders come back after missing Monday’s overseas action. U.S. stocks climbed Monday, led by a rebound in chip stocks after last week’s drop. Some signs that Middle East tensions eased also helped, leaving Australians returning to a stronger offshore lead than they had before the market closed on Friday.
June 8, 2026
Sigma Healthcare Share Price Jumps 4.5% After Jefferies Upgrade Revives Chemist Warehouse Focus

Sigma Healthcare Share Price Jumps 4.5% After Jefferies Upgrade Revives Chemist Warehouse Focus

Sigma Healthcare jumped 4.5% to A$2.78 on March 20, landing the Chemist Warehouse owner near the top of the blue-chip board. Jefferies bumped its rating to buy from hold, tagging a A$3.05 target price. This one stood out—trading volume surged to 103 million shares, a sharp leap from the 10.9 million to 19.5 million range seen over the previous four sessions. Even with Friday’s bounce, the stock remained roughly 5.4% lower for the year.
March 22, 2026